Atlantic Health Strategies logo
LinkedIn icon
Contact Us

Atlantic Health Strategies

X-twitter Linkedin
Atlantic Health Strategies Logo

Payer Guidelines for Behavioral Health Operators: ASAM 4th Edition, Wit v. UBH, and Parity Enforcement in 2026

Table of Contents

Ready to See Results?

From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.

Contact Us

The Short Answer: Payer Guidelines Decide Whether You Get Paid

Payer guidelines are the written medical necessity and utilization management criteria a health plan uses to decide whether a behavioral health admission, continued stay, or discharge gets reimbursed. If your chart does not speak the exact criteria set the payer is scoring against, you will not get paid. For adult substance use disorder care, most national payers now anchor those decisions in The ASAM Criteria, 4th Edition.

Optum Behavioral Health, UnitedHealth’s behavioral health arm, spelled out the timing on its own provider site: beginning in November 2023, Optum began implementing The ASAM Criteria, 4th Edition, for adult SUD, with Medicaid plans not transitioning until Jan. 1, 2025 at the earliest. Same page: the 4th Edition changes are not effective until a facility has a fully executed, updated contract with Optum. For mental health levels of care, payers lean on MCG Health or LOCUS/CALOCUS-CASII.

Three things matter operationally.

  • Your clinicians document to the criteria set the payer actually uses.
  • Your UR staff knows the reauthorization cadence for each payer.
  • Your intake assessment is structured around the six ASAM dimensions, because that is how the reviewer on the other end of the phone is scoring you.

The demand side is real. KFF’s analysis of 2024 federal transparency data found HealthCare.gov insurers denied 19% of in-network claims, roughly 85 million claims out of 451 million in-network claims filed. Your revenue lives or dies by whether your chart matches the payer’s criteria.

Why Payer Criteria Vary So Much (and Why It Costs You Money)

There is no single national medical necessity standard. Aetna publishes its own list. Cigna/Evernorth publishes its own. Most large commercial payers use MCG (formerly Milliman Care Guidelines), InterQual, or their own proprietary criteria. Layer on state Medicaid rules and the picture gets messier fast.

The financial impact is not abstract. Premier’s national survey of 516 hospitals found nearly 15% of medical claims submitted to private payers are initially denied, and providers spend roughly $19.7 billion a year just to adjudicate those denials, with $10.6 billion of that “wasted arguing over claims that should have been paid at the time of submission.” Premier’s follow-up survey pushed that figure to $25.7 billion in claims adjudication costs, a 23% jump year over year. The top denial reasons: missing or inaccurate data, authorization issues, and incomplete patient information.

I watched a Florida residential withdrawal management program lose $180,000 in a single quarter because the clinical team was documenting against 3rd-edition ASAM language while Optum was scoring against the 4th. The mismatch was invisible until the denials hit. Operators need to know exactly what edition their fee-for-service and Medicaid book of business is being adjudicated against on any given day.

The 4th Edition also restructured the outpatient continuum. Per NAATP’s summary of the ASAM implementation webinar with Optum, Level 2.7 Medically Managed Intensive Outpatient is a new level requiring both clinical and medical services for 20+ hours per week, and Level 2.5 High-Intensity Outpatient replaces the old PHP model with no medical component. PHP remains an outpatient level of care.

What Wit v. United Behavioral Health Actually Changed (and Didn't)

Every operator should understand Wit. In 2019, the U.S. District Court for the Northern District of California found that UBH adopted medical necessity guidelines that deviated from generally accepted clinical standards of care for mental health and addiction. Per The Kennedy Forum’s case history, Judge Spero ordered UBH to reprocess upwards of 67,000 coverage claims for 50,000 patients, half of whom were children.

Then it got complicated. On August 22, 2023, the Ninth Circuit vacated its January 2023 ruling and remanded the fiduciary duty question, plus the plaintiffs’ responsibility to exhaust administrative appeals, back to the district court. Zuckerman Spaeder partner Caroline Reynolds, who represents the plaintiffs, told Behavioral Health Business: “It is remarkable and commendable that the panel has now twice reconsidered its rulings and has substantially resurrected a generationally important mental health ruling.”

On remand, the district court reaffirmed that UBH breached its fiduciary duties of loyalty and care by designing internal coverage guidelines to favor its financial interests over those of participants. The remedy question is still open.

Several states have codified ASAM-consistent criteria on top of the payer’s own rules. The DeBofsky Law analysis notes that one class of Wit plaintiffs challenged denials based on UBH’s usage of guidelines that were inconsistent with state-mandated behavioral health treatment guidelines in Texas, Illinois, Connecticut and Rhode Island. Operators writing multi-state contracts need to know which of theirs carries a state ASAM mandate on top of the payer’s criteria.

Parity, NQTLs, and the Enforcement Picture Operators Need to Track

Payer guidelines are also a parity issue. The Mental Health Parity and Addiction Equity Act of 2008, amended by the Consolidated Appropriations Act of 2021, requires plans to perform a comparative analysis of nonquantitative treatment limitations (NQTLs) like prior authorization, step therapy, and medical necessity rules.

On May 15, 2025, DOL, HHS, and Treasury announced enforcement relief. The tri-agency statement said: “The Departments will not enforce the 2024 Final Rule or otherwise pursue enforcement actions, based on a failure to comply that occurs prior to a final decision in the litigation, plus an additional 18 months.” The same statement makes clear that MHPAEA’s statutory obligations, as amended by the CAA 2021, continue to have effect, and the enforcement relief applies only to the portions of the 2024 Final Rule that are new in relation to the 2013 final rule.

Translation for operators: comparative analysis is still required by statute, the 2013 rules still apply, and EBSA is still investigating. Groom Law Group’s analysis puts it plainly: the longstanding NQTL rule from the 2013 final rules, as well as the CAA 2021 provisions, remain in force. Private plaintiffs can also still sue under ERISA § 502 for pre-existing causes of action under MHPAEA. Behavioral health carve-outs and network-composition NQTLs are still live enforcement targets under the 2013 framework.

The market context is not friendly to sloppy plans either. Consumers appealed less than 1% of denied claims in the KFF data set. That is the reviewer pool your UR team is fighting.

How AHS Operationalizes Payer Guidelines for Florida and Multi-State Operators

For Florida operators, the layered regulatory picture is real. DCF licenses all facilities providing SUD treatment services, including detox, residential, PHP, and IOP. AHCA licenses mental health treatment services including residential treatment centers and standalone mental health PHP and IOP programs. Co-occurring programs typically need dual licensure. On top of that sits Statewide Medicaid Managed Care, each MCO with its own authorization rules, and the commercial payers running their own UM playbooks.

Here is how our team runs a payer-guidelines engagement:

  1. Our analysts map every active payer contract to the specific criteria set it uses (ASAM 4th Edition for adult SUD, MCG for most commercial MH, LOCUS for some carve-outs).
  2. Our clinical leadership rewrites intake and continued-stay templates so they speak the language of the six ASAM dimensions, incorporating the structural changes in the 4th Edition, including the new Level 2.7 Medically Managed Intensive Outpatient and Level 2.5 High-Intensity Outpatient that replaces the old PHP model.
  3. Our reviewers run mock concurrent reviews against your last 90 days of charts and quantify the denial exposure.
  4. Our UM team builds an authorization cadence that prevents lapses, because the denials we see are almost always preventable.

State adoption is uneven. Kentucky adopted the 4th Edition at the Medicaid level effective June 25, 2025. Illinois followed on July 1, 2025, when IDHS/SUPR began issuing licenses reflecting The ASAM Criteria, 4th Edition levels of care. In most other states, Medicaid contracts with Optum remain based on the 3rd Edition until further notice.

Your clinicians should document to the criteria the payer actually uses, dimension by dimension. That is how you stop leaking revenue.

Frequently asked questions

Which ASAM Criteria edition should our clinical team document against in 2026?

It depends on the payer, the state, and the patient’s age. Optum began implementing The ASAM Criteria, 4th Edition in November 2023 for adult SUD on commercial plans, with Medicaid transitions not starting until Jan. 1, 2025 at the earliest, and the 4th Edition is not effective for a given facility until it has a fully executed, updated contract with Optum (source: Optum Provider Express). Kentucky adopted the 4th Edition at the Medicaid level effective June 25, 2025, and Illinois followed on July 1, 2025, when IDHS/SUPR began issuing licenses reflecting the 4th Edition levels of care. In most other states, Medicaid contracts with Optum remain on the 3rd Edition. The 4th Edition adult volume is adults only; clinicians continue to use 3rd Edition criteria for adolescents under 18 until the adolescent volume is published (ASAM has scheduled that for Spring 2026).

Does the Wit v. UBH decision still protect our clients’ coverage rights?

Partially. The Ninth Circuit’s August 22, 2023 opinion vacated its January 2023 ruling and remanded the fiduciary duty and administrative exhaustion questions to the district court. On remand, the district court reaffirmed that UBH breached its fiduciary duties of loyalty and care by designing internal coverage guidelines to favor its financial interests over those of participants (source: The Kennedy Forum case tracker). Texas, Illinois, Connecticut and Rhode Island were named in the plaintiffs’ challenge to guidelines inconsistent with state-mandated behavioral health treatment criteria (source: DeBofsky Law). Operators should still document to generally accepted standards and appeal denials that deviate from them.

Are health plans still required to do a parity NQTL comparative analysis after the 2025 enforcement pause?

Yes. On May 15, 2025, DOL, HHS, and Treasury announced they will not enforce the 2024 Final Rule until a final decision in the ERIC litigation plus an additional 18 months, but the same statement explicitly confirmed that MHPAEA’s statutory obligations, as amended by the CAA 2021, continue to have effect (source: DOL). Plans must still produce a written NQTL comparative analysis on request, the 2013 final rule still applies, and private ERISA § 502 litigation is unaffected by the enforcement pause. The 2024 rule’s fiduciary certification requirement is not enforceable during the relief period, but the underlying comparative analysis obligation is (source: Groom Law Group).

What is the single highest-yield change an operator can make to reduce medical necessity denials?

Rewrite intake and continued-stay documentation so it is structured around the six ASAM dimensions and matches the specific criteria set each payer uses. KFF’s analysis of 2024 HealthCare.gov data found insurers denied 19% of in-network claims, roughly 85 million out of 451 million filed, and consumers appealed less than 1% of them, so the chart has to speak the payer’s language on the first submission or the reviewer will find a reason to deny. Premier’s national survey estimates hospitals and health systems now spend roughly $19.7 billion a year (rising to $25.7 billion in the 2025 update) managing denied claims; documentation aligned to the payer’s criteria set is the cheapest place to attack that number.

References

Request a Free Consultation

Scroll to Top